Advanced search
Publication Cover
Emerging Microbes & Infections Volume 3, 2014 - Issue 1
Submit an article Journal homepage
2,014
Views
108
CrossRef citations to date
0
Altmetric
Original Articles

Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis

Wanliang ShiDepartment of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
,
Jiazhen ChenDepartment of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200040, China
,
Jie FengDepartment of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
,
Peng CuiDepartment of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200040, China
,
Shuo ZhangDepartment of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
,
Xinhua WengDepartment of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200040, China
,
Wenhong ZhangDepartment of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200040, ChinaCorrespondence[email protected] [email protected]
&
Ying ZhangDepartment of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA;Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200040, ChinaCorrespondence[email protected] [email protected]
 show all
Pages 1-8 | Received 23 Sep 2015, Accepted 02 Nov 2015, Published online: 25 Jan 2019

  • Zhang Y, Chang K, Leung C et al.“ZS-MDR-TB” versus “ZR-MDR-TB”: Improving Treatment of MDR-TB by Identifying Pyrazinamide Susceptibility. Emerg Microbes Infect2012;1: e5.
  • World Health Organization. Treatment of tuberculosis: guidelines, Fourth edition.Geneva: WHO, 2010.Available at http://www.who.int/tb/publications/2010/9789241547833/en/ (accessed 28 June 2014).
  • Zhang Y, Shi W, Zhang W, Denis Mitchison.Mechanisms of Pyrazinamide Action and Resistance. Microbiol Spectrum2014;2: 2.4.03.
  • Zhang Y, Mitchison D.The curious characteristics of pyrazinamide: a review. Int J Tuberc Lung Dis2003;7: 6–21.
  • Scorpio A, Zhang Y.Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat Med1996;2: 662–667.
  • Scorpio A, Lindholm-Levy P, Heifets L et al.Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother1997;41: 540–543.
  • Shi W, Zhang X, Jiang X et al.Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis. Science2011;333: 1630–1632.
  • Tan Y, Hu Z, Zhang T et al.Role of pncA and rpsA gene sequencing in detection of pyrazinamide resistance in Mycobacterium tuberculosis isolates from southern China. J Clin Microbiol2014;52: 291–297.
  • Simons SO, Mulder A, van Ingen J, Boeree MJ, van Soolingen D.Role of rpsA gene sequencing in diagnosis of pyrazinamide resistance. J Clin Microbiol2013;51: 382.
  • Feuerriegel S, Koser CU, Richter E, Niemann S.Mycobacterium canettii is intrinsically resistant to both pyrazinamide and pyrazinoic acid. J Antimicrob Chemother2013;68: 1439–1440.
  • Alexander DC, Ma JH, Guthrie JL, Blair J, Chedore P, Jamieson FB.Gene sequencing for routine verification of pyrazinamide resistance in Mycobacterium tuberculosis: a role for pncA but not rpsA. J Clin Microbiol2012;50: 3726–3728.
  • Zhang S, Chen J, Shi W, Liu W, Zhang WH, Zhang Y.Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis. Emerg Microbes Infect2013;2: e34.
  • Zheng H, Lu L, Wang B et al.Genetic basis of virulence attenuation revealed by comparative genomic analysis of Mycobacterium tuberculosis strain H37Ra versus H37Rv. PLoS One2008;3: e2375.
  • Ehrt S, Guo XV, Hickey CM et al.Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor. Nucleic Acids Res2005;33: e21.
  • Zhang Y, Garbe T, Young D.Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations. Mol Microbiol1993;8: 521–524.
  • Zhang Y, Permar S, Sun Z.Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide. J Med Microbiol2002;51: 42–49.
  • Chopra S, Pai H, Ranganathan A.Expression, purification, and biochemical characterization of Mycobacterium tuberculosis aspartate decarboxylase, PanD. Protein Expr Purif2002;25: 533–540.
  • Zhang Y, Scorpio A, Nikaido H, Sun Z.Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide. J Bacteriol1999;181: 2044–2049.
  • Gopalan G, Chopra S, Ranganathan A, Swaminathan K.Crystal structure of uncleaved L-aspartate-alpha-decarboxylase from Mycobacterium tuberculosis. Proteins2006;65: 796–802.
  • Zhang Y, Yew WW, Barer MR.Targeting persisters for tuberculosis control. Antimicrob Agents Chemother2012;56: 2223–2230.
  • Sizemore C, Schleif AC, Bernstein JB, Heilman CA.The role of biomedical research in global tuberculosis control: gaps and challenges. Emerg Microbes Infect2012;1: e9.
  • Zhang Y.Persisters, Persistent Infections and the Yin-Yang Model. Emerg Microbes Infect2014;3: e3.
  • Zhang Y, Wade MM, Scorpio A, Zhang H, Sun Z.Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. J Antimicrob Chemother2003;52: 790–795.
  • Darby CM, Ingolfsson HI, Jiang X et al.Whole cell screen for inhibitors of pH homeostasis in Mycobacterium tuberculosis. PLoS One2013;8: e68942.
  • Sambandamurthy VK, Wang X, Chen B et al.A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis. Nat Med2002;8: 1171–1174.
  • Sharma R, Kothapalli R, Van Dongen AM, Swaminathan K.Chemoinformatic identification of novel inhibitors against Mycobacterium tuberculosis L-aspartate alpha-decarboxylase. PLoS One2012;7: e33521.
  • White EL, Southworth K, Ross L et al.A novel inhibitor of Mycobacterium tuberculosis pantothenate synthetase. J Biomol Screen2007;12: 100–105.
  • Kumar A, Casey A, Odingo J et al.A high-throughput screen against pantothenate synthetase (PanC) identifies 3-biphenyl-4-cyanopyrrole-2-carboxylic acids as a new class of inhibitor with activity against Mycobacterium tuberculosis. PLoS One2013;8: e72786.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.